In stomach adenocarcinoma cells, GPx3 inhibited the level of pyrimidine metabolism via the ROS/AMPK/mTOR signaling pathway, which could affect the migration and invasive ability of these cancer cells and provide ways to reduce their drug resistance [138]. Here, GPX3 is linked to cancer.